Apeloa Pharmaceutical Co Ltd (000739) — Net Asset Quality Index

Latest as of March 2026: 53.6%

Apeloa Pharmaceutical Co Ltd (000739) has a Net Asset Quality Index of 53.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥12.25 Billion minus total liabilities of CN¥5.68 Billion yields net assets of CN¥6.57 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Apeloa Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Quality Index

53.6%
Equity / Total Assets

Net Assets

CN¥6.57 Billion
CNY

Total Assets

CN¥12.25 Billion
CNY

Total Liabilities

CN¥5.68 Billion
CNY

Apeloa Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1994–2025)

This chart shows how Apeloa Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 32 annual periods from 1994 to 2025. As of March 2026, the index stands at 53.6%, representing net assets of CN¥6.57 Billion against total assets of CN¥12.25 Billion CNY. See how liquid is Apeloa Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Apeloa Pharmaceutical Co Ltd (1994–2025)

The table below presents the year-by-year Net Asset Quality Index for Apeloa Pharmaceutical Co Ltd from 1994 to 2025, covering 32 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Apeloa Pharmaceutical Co Ltd market capitalisation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 51.5% CN¥6.35 Billion CN¥12.32 Billion CN¥5.97 Billion ▼ -1.5 pp
2024 53.0% CN¥6.75 Billion CN¥12.73 Billion CN¥5.98 Billion ▲ +4.2 pp
2023 48.8% CN¥6.23 Billion CN¥12.77 Billion CN¥6.54 Billion ▲ +2.9 pp
2022 45.9% CN¥5.52 Billion CN¥12.02 Billion CN¥6.50 Billion ▼ -10.0 pp
2021 55.9% CN¥5.06 Billion CN¥9.04 Billion CN¥3.98 Billion ▼ -2.6 pp
2020 58.6% CN¥4.39 Billion CN¥7.49 Billion CN¥3.10 Billion ▲ +0.8 pp
2019 57.8% CN¥3.77 Billion CN¥6.52 Billion CN¥2.75 Billion ▼ -0.4 pp
2018 58.2% CN¥3.35 Billion CN¥5.75 Billion CN¥2.41 Billion ▲ +4.6 pp
2017 53.6% CN¥3.05 Billion CN¥5.69 Billion CN¥2.64 Billion ▲ +7.0 pp
2016 46.6% CN¥2.62 Billion CN¥5.62 Billion CN¥3.00 Billion ▲ +1.8 pp
2015 44.8% CN¥2.42 Billion CN¥5.39 Billion CN¥2.98 Billion ▼ -0.8 pp
2014 45.6% CN¥2.31 Billion CN¥5.06 Billion CN¥2.76 Billion ▲ +5.7 pp
2013 39.8% CN¥1.86 Billion CN¥4.66 Billion CN¥2.80 Billion ▲ +6.6 pp
2012 33.2% CN¥1.37 Billion CN¥4.11 Billion CN¥2.74 Billion ▼ -0.7 pp
2011 34.0% CN¥1.23 Billion CN¥3.63 Billion CN¥2.40 Billion ▼ -9.9 pp
2010 43.8% CN¥808.57 Million CN¥1.84 Billion CN¥1.04 Billion ▼ -1.6 pp
2009 45.4% CN¥794.78 Million CN¥1.75 Billion CN¥954.91 Million ▲ +1.3 pp
2008 44.1% CN¥768.11 Million CN¥1.74 Billion CN¥973.00 Million ▼ -2.4 pp
2007 46.5% CN¥750.11 Million CN¥1.61 Billion CN¥864.02 Million ▲ +12.0 pp
2006 34.5% CN¥436.05 Million CN¥1.26 Billion CN¥828.68 Million ▼ -1.5 pp
2005 36.0% CN¥411.93 Million CN¥1.14 Billion CN¥732.94 Million ▲ +2.7 pp
2004 33.3% CN¥371.08 Million CN¥1.11 Billion CN¥743.40 Million ▼ -4.8 pp
2003 38.1% CN¥328.83 Million CN¥863.07 Million CN¥534.24 Million ▼ -4.5 pp
2002 42.6% CN¥293.69 Million CN¥689.28 Million CN¥395.59 Million ▼ -1.6 pp
2001 44.2% CN¥259.70 Million CN¥587.38 Million CN¥327.67 Million ▼ -16.5 pp
2000 60.7% CN¥274.23 Million CN¥452.01 Million CN¥177.79 Million ▲ +1.5 pp
1999 59.2% CN¥307.93 Million CN¥520.33 Million CN¥212.40 Million ▲ +9.3 pp
1998 49.9% CN¥226.31 Million CN¥453.48 Million CN¥227.17 Million ▼ -6.5 pp
1997 56.4% CN¥221.45 Million CN¥392.71 Million CN¥171.26 Million ▲ +25.9 pp
1996 30.5% CN¥50.12 Million CN¥164.37 Million CN¥114.25 Million ▼ -2.2 pp
1995 32.7% CN¥47.79 Million CN¥146.29 Million CN¥98.50 Million ▲ +7.7 pp
1994 25.0% CN¥35.35 Million CN¥141.51 Million CN¥106.16 Million
pp = percentage points